Conclusion: The outlook for state Medicaid coverage of GLP-1 AOMs While 13 state Medicaid programs covered at least one GLP-1 approved for weight management as of August 2024, states subsequently reversed course: California, New Hampshire, Pennsylvania, and South Carolina recently withdrew coverage
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
If youve missed your dose for over two weeks, its important to consult your healthcare provider to discuss how to resume your treatment effectively
In recent years, semaglutide has risen to prominence in the search for new methods of weight loss
A 3-week multicentre randomized controlled trial (ALADIN Study)
Both support tissue repair from complementary angles